Highlights and Quick Summary
- Non-current Liabilities (Other) for the quarter ending September 30, 2022 was $33.6 Million (a 1.28% increase compared to previous quarter)
- Year-over-year quarterly Non-current Liabilities (Other) decreased by -9.73%
- Annual Non-current Liabilities (Other) for 2021 was $37.2 Million (a 404.23% increase from previous year)
- Annual Non-current Liabilities (Other) for 2020 was $7.37 Million (a 52.64% increase from previous year)
- Annual Non-current Liabilities (Other) for 2019 was $4.83 Million (a -34.72% decrease from previous year)
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Non-current Liabilities (Other) of Beam Therapeutics Inc.
Most recent Non-current Liabilities (Other)of BEAM including historical data for past 10 years.Interactive Chart of Non-current Liabilities (Other) of Beam Therapeutics Inc.
Beam Therapeutics Inc. Non-current Liabilities (Other) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $33.55 | $33.13 | $44.41 | – |
| 2021 | $37.17 | $31.41 | $42.64 | $42.9 | $37.17 |
| 2020 | $7.37 | $6.94 | $5.3 | $5.75 | $7.37 |
| 2019 | – | – | – | $4.83 | $4.83 |
| 2018 | – | – | – | $7.4 | $7.4 |
| 2017 | – | – | – | – | $0.0 |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology